AKT1 E17K + HR positive
|
HER2 Negative Breast Cancer
|
AKT1 E17K + HR positive
|
HER2 Negative Breast Cancer
|
AZD5363 Sensitive: C3 – Early Trials
|
AZD5363 Sensitive: C3 – Early Trials
|
AKT1 E17K + HR positive
|
HER2 Negative Breast Cancer
|
AKT1 E17K + HR positive
|
HER2 Negative Breast Cancer
|
M2698 Sensitive: C4 – Case Studies
|
M2698 Sensitive: C4 – Case Studies
|